Tag Archives: hormones

Featured Sessions and Perspectives from The A4M Women’s Health Summit

The energy from the sold-out 2025 Women’s Health Summit in Scottsdale continues to reverberate. Between October 9-11, practitioners gathered at The Westin Kierland for an intensive deep-dive into menopause medicine, emerging from three days armed with protocols, data, and strategies that directly address the most pressing challenge in women’s healthspan optimization: menopause. 

Our second-ever Summit delivered on its promise to equip providers to empower their patients’ journeys through this consequential and long-lasting hormonal transition. A lineup of leading female health experts presented evidence-based frameworks spanning metabolic health, hormone optimization, genetic influences, musculoskeletal preservation, mental health support, and systemic healthcare reform. Each session provided immediately applicable clinical tools designed to elevate women’s health outcomes in practice.

Continue reading

The Androgen Clock: Decoding Epigenetic Evidence Of Hormone History

Biological history encoded within DNA reveals crucial information about health trajectories, aging patterns, and disease risks. For decades, healthcare providers have relied on hormone testing methods that capture mere snapshots – transient measurements failing to reflect lifelong hormone interactions. As a result of this fundamental limitation, our understanding and treatment of hormone-related conditions affecting millions worldwide has remained profoundly incomplete, missing critical patterns of cumulative exposure that drive disease progression and accelerate aging processes.

Enter the androgen clock – a groundbreaking diagnostic innovation analyzing DNA methylation to establish comprehensive, long-term records of androgen exposure.

Continue reading

Best Of 2024: A4M Recaps The Top Longevity Developments In 2024

Best of 2024: The Stories That Defined Longevity

Medicine stopped asking “what if” and started delivering “what’s next” in 2024.

Familiar drugs revealed new powers – GLP-1s protected brain tissue while reshaping metabolic health. Psychedelic therapy protocols moved from promising data to proven results. Anti-aging treatments once reserved for elite clinics found their way to neighborhood practices. Meanwhile, in pop-up enclaves across the globe, independent communities merged Web3 tools with longevity research, questioning every assumption about how science advances.

Yet, as medical possibilities soared to new heights, U.S. life expectancy data laid bare the chasm between medical capability and public health reality. This stark contrast forced hard questions about implementation – not just of new treatments, but of medical education itself.

Real-time analysis from the A4M Blog translated emerging science into practical guidance. From hormone optimization advances in menopause care to supplement safety investigations that exposed dangerous oversight gaps, each new revelation spurred meaningful progress in modern healthcare.

Continue reading